Researchers have reported an extraordinary long-term remission in a rare and severe autoimmune condition known as neuromyelitis optica spectrum disorder (NMOSD), which affects the optic nerves and spinal cord. The disease can lead to vision loss, paralysis, and loss of bladder or bowel control due to immune system attacks on the nervous system.
Stem Cell Transplant Offers Lasting Control
To treat the condition, scientists used allogeneic hematopoietic stem cell transplantation, in which healthy donor stem cells replace a patient’s faulty immune system. Two patients who underwent this procedure more than 15 years ago have now remained completely relapse-free without ongoing immunosuppressive therapy.
Profound Immune Reset Observed
The treatment effectively eliminated disease-causing antibodies (AQP4-IgG), which stayed undetectable throughout long-term follow-up. In addition, doctors confirmed that the patients’ original immune systems were fully replaced by donor-derived immune cells, indicating a complete immune reset.
According to Medical Xpress
As reported by Medical Xpress, both patients showed sustained neurological stability during regular follow-ups involving MRI scans, antibody testing, and clinical evaluations. Importantly, neither patient experienced any disease relapses over a period of 15–16 years after transplantation.
Improved Quality of Life
Beyond disease control, both individuals experienced meaningful improvements in quality of life. One patient regained significant physical ability and later started a family, while the other, despite pre-existing disability, gained improved independence and daily functioning.
Conclusion: Strong Evidence but Limited Scope
Researchers emphasized that these results provide strong proof of concept for stem cell transplantation in severe, treatment-resistant NMOSD. However, they also noted that larger studies are needed to better understand patient selection, safety, and long-term outcomes before broader application.